ZNF652 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.022040E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.803700E-02
Normal-vs-Stage2
8.659600E-03
Normal-vs-Stage3
1.638220E-02
Normal-vs-Stage4
1.817390E-01
Stage1-vs-Stage2
4.966800E-01
Stage1-vs-Stage3
3.593800E-02
Stage1-vs-Stage4
8.991400E-01
Stage2-vs-Stage3
5.565700E-02
Stage2-vs-Stage4
6.911200E-01
Stage3-vs-Stage4
1.702610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.169780E-02
Normal-vs-AfricanAmerican
7.114500E-02
Normal-vs-Asian
3.412500E-02
Caucasian-vs-AfricanAmerican
7.754600E-01
Caucasian-vs-Asian
8.389400E-01
AfricanAmerican-vs-Asian
7.149000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.730200E-02
Normal-vs-Female
7.181900E-03
Male-vs-Female
9.141800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.790160E-01
Normal-vs-Age(41-60Yrs)
3.963500E-02
Normal-vs-Age(61-80Yrs)
7.555200E-03
Normal-vs-Age(81-100Yrs)
1.603940E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.460800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.433600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.664000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.651850E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.982000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.380400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.542600E-03
Normal-vs-Daily Drinker
3.631600E-02
Normal-vs-Weekly Drinker
9.859900E-03
Normal-vs-Occasional Drinker
4.180300E-02
Normal-vs-Social Drinker
8.379900E-02
Non Drinker-vs-Daily Drinker
6.534200E-01
Non Drinker-vs-Weekly Drinker
8.863000E-01
Non Drinker-vs-Occasional Drinker
8.249900E-02
Non Drinker-vs-Social Drinker
6.530500E-02
Daily Drinker-vs-Weekly Drinker
8.123200E-01
Daily Drinker-vs-Occasional Drinker
3.246400E-01
Daily Drinker-vs-Social Drinker
2.696000E-01
Weekly Drinker-vs-Occasional Drinker
1.942040E-01
Weekly Drinker-vs-Social Drinker
1.638390E-01
Occasional Drinker-vs-Social Drinker
8.136800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.222100E-02
Normal-vs-Grade 2
7.193300E-04
Normal-vs-Grade 3
1.163900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.585000E-01
Grade 1-vs-Grade 3
4.852000E-02
Grade 1-vs-Grade 4
2.222100E-02
Grade 2-vs-Grade 3
8.159600E-02
Grade 2-vs-Grade 4
7.193300E-04
Grade 3-vs-Grade 4
1.163900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.898300E-03
Normal-vs-NonDiabetic
1.642320E-02
Diabetic-vs-NonDiabetic
6.484400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.756900E-03
Normal-vs-NoPancreatitis
7.924800E-03
Pancreatitis-vs-NoPancreatitis
9.199800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.379640E-02
Normal-vs-N1
1.133980E-02
N0-vs-N1
7.805000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.123700E-02
Normal-vs-TP53-NonMutant
1.781640E-01
TP53-Mutant-vs-TP53-NonMutant
3.098000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
